We are live on
!
Find out more
HWA
HCR Wealth Advisors Portfolio holdings
AUM
$1.12B
1-Year Est. Return
33.13%
This Fund
S&P 500
This Quarter
Est. Return
+3.95%
1 Year Est. Return
+33.13%
3 Year Est. Return
+90.97%
5 Year Est. Return
+118.97%
10 Year Est. Return
–
AUM
$798M
AUM Growth
+$34M
(+4.5%)
Cap. Flow
+$11.1M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
57.88%
Holding
240
New
11
Increased
93
Reduced
78
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$3.36M |
| 2 |
Vanguard Morningstar Growth ETF
VUG
|
+$3.19M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$2.57M |
| 4 |
TransDigm Group
TDG
|
+$2.52M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$3.22M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$1.07M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$571K |
| 4 |
First Trust Preferred Securities and Income ETF
FPE
|
+$557K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$291K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.51% |
| 2 | Financials | 6.01% |
| 3 | Communication Services | 4.98% |
| 4 | Industrials | 4.95% |
| 5 | Consumer Discretionary | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Rivian
RIVN
$24.4B
| $133K | 0.02% |
+10,030
| New | +$115K |
|
227
Nokia
NOK
$50.7B
| $68.2K | 0.01% |
15,405
| – | – |
|
228
Editas Medicine
EDIT
$413M
| $21.6K | ﹤0.01% |
17,000
| – | – |
|
229
Comcast
CMCSA
$84B
| – | – |
-5,035
| Closed | -$210K |
|
230
Danaher
DHR
$138B
| – | – |
-933
| Closed | -$259K |
|
231
Consolidated Edison
ED
$40.4B
| – | – |
-2,186
| Closed | -$228K |
|
|
CBIO
232
Crescent Biopharma
CBIO
$555M
| – | – |
-1,000
| Closed | -$16.9K |
|
233
Martin Marietta Materials
MLM
$32.4B
| – | – |
-425
| Closed | -$229K |
|
234
Micron Technology
MU
$988B
| – | – |
-2,363
| Closed | -$245K |
|
235
Public Service Enterprise Group
PEG
$38.6B
| – | – |
-2,319
| Closed | -$207K |
|
236
QuantumScape Corp
QS
$3.22B
| – | – |
-10,000
| Closed | -$57.5K |
|
|
237
Regeneron Pharmaceuticals
REGN
$77.4B
| – | – |
-277
| Closed | -$291K |
|
238
Schwab US Dividend Equity ETF
SCHD
$103B
| – | – |
-7,098
| Closed | -$200K |
|
239
Target
TGT
$65.6B
| – | – |
-1,503
| Closed | -$234K |
|
240
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| – | – |
-2,414
| Closed | -$202K |
|
Similar funds
CNC
MTCM
AIM
C
FLAM
CT
SL
RIM
HCR Wealth Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, HCR Wealth Advisors held 240 positions worth $798M, up 4.5% from $764M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
HCR Wealth Advisors's Q4 2024 filing shows 11 new, 93 increased, 78 reduced and 12 closed positions. Its largest new stake was TransDigm Group: 1,914 shares worth $2.43M. The largest sale was Ametek, an estimated $3.22M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Communication Services.
- HCR Wealth Advisors's largest Q4 2024 buy was TransDigm Group: 1,914 shares worth $2.43M.
- HCR Wealth Advisors added most to Vanguard High Dividend Yield ETF in Q4 2024, an estimated $3.36M increase.
- HCR Wealth Advisors's biggest Q4 2024 reduction was Ametek, cutting an estimated $3.22M.
- HCR Wealth Advisors fully exited Regeneron Pharmaceuticals in Q4 2024, selling an estimated $291K.
- HCR Wealth Advisors's ten largest holdings make up 58% of its $798M portfolio in Q4 2024.
- HCR Wealth Advisors opened 11 new positions and closed 12 in Q4 2024.
- HCR Wealth Advisors's portfolio value rose 4.5% quarter-over-quarter to $798M.
Based on HCR Wealth Advisors's 13F filing for Q4 2024, filed 14 Jan 2025.